Transgenic Mice with Neurofilament Abnormalities

[1]  Q. Zhu,et al.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Q. Zhu,et al.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Julien,et al.  Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.

[4]  B. Giasson,et al.  Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments* , 1996, The Journal of Biological Chemistry.

[5]  T. Crawford,et al.  Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport , 1996, The Journal of cell biology.

[6]  J. Gallo,et al.  Aggregation of Neurofilaments in NF‐L Transfected Neuronal Cells: Regeneration of the Filamentous Network by a Protein Kinase C Inhibitor , 1996, Journal of neurochemistry.

[7]  C. Klee,et al.  Superoxide dismutase protects calcineurin from inactivation , 1996, Nature.

[8]  L. Bruijn,et al.  Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[9]  E. Fuchs,et al.  An Essential Cytoskeletal Linker Protein Connecting Actin Microfilaments to Intermediate Filaments , 1996, Cell.

[10]  S. Meloche,et al.  Inhibition of Growth Factor-induced Protein Synthesis by a Selective MEK Inhibitor in Aortic Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.

[11]  F. Cacucci,et al.  Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant. , 1996, Brain research. Molecular brain research.

[12]  S. M. Chou,et al.  Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study , 1996, Journal of Chemical Neuroanatomy.

[13]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[14]  S. Sasaki,et al.  Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis , 1996, Neurology.

[15]  M. Gurney,et al.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Cleveland.  Neuronal Growth and Death: Order and Disorder in the Axoplasm , 1996, Cell.

[17]  G. Rouleau,et al.  Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis , 1996, Neurology.

[18]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[19]  Guy A. Rouleau,et al.  SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .

[20]  T. Crawford,et al.  Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons , 1995, The Journal of cell biology.

[21]  L. Descarries,et al.  Abnormal perikaryal accumulation of neurofilament light protein in the brain of mice transgenic for the human protein: Sequence of postnatal development , 1995, Neuroscience.

[22]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[23]  Mark A. Smith,et al.  Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease , 1995, Journal of neurochemistry.

[24]  J. Julien,et al.  Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.

[25]  J. A. Cohlberg,et al.  Neurofilament Protein Heterotetramers as Assembly Intermediates (*) , 1995, The Journal of Biological Chemistry.

[26]  Robert H. Brown,et al.  Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.

[27]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Trojanowski,et al.  Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  J. Melki,et al.  Early detection of mouse wobbler mutation: a model of pathological motoneurone death. , 1994, Neuroreport.

[30]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[31]  D. Cleveland,et al.  A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.

[32]  R. Lazzarini,et al.  Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  M. Strong.  Aluminum neurotoxicity: An experimental approach to the induction of neurofilamentous inclusions , 1994, Journal of the Neurological Sciences.

[34]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[35]  E. Fuchs,et al.  Intermediate filaments and disease: mutations that cripple cell strength , 1994, The Journal of cell biology.

[36]  M. Somerville,et al.  Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons , 1994, Journal of neuropathology and experimental neurology.

[37]  A. Peterson,et al.  Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein , 1994, Neuron.

[38]  N. Hirokawa,et al.  Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. , 1993, The Journal of biological chemistry.

[39]  L. Cork,et al.  Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[40]  R. Liem,et al.  Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments , 1993, The Journal of cell biology.

[41]  P. Wong,et al.  Neurofilaments are obligate heteropolymers in vivo , 1993, The Journal of cell biology.

[42]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[43]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[44]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[45]  Scott T. Brady,et al.  Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.

[46]  N. Hirokawa,et al.  Molecular architecture of the neurofilament. II. Reassembly process of neurofilament L protein in vitro. , 1990, Journal of molecular biology.

[47]  Scott T. Brady,et al.  Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging , 1989, Neurobiology of Aging.

[48]  F. Grosveld,et al.  Sequence and structure of the mouse gene coding for the largest neurofilament subunit. , 1988, Gene.

[49]  R. Lazzarini,et al.  The structure and organization of the human heavy neurofilament subunit (NF‐H) and the gene encoding it. , 1988, The EMBO journal.

[50]  V. Lee,et al.  Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[51]  A. Hirano,et al.  Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.

[52]  D. Price,et al.  Cytoskeletal disorganization induced by local application of β,β′‐iminodipropionitrile and 2,5‐hexanedione , 1983, Annals of neurology.

[53]  J. Julien,et al.  Multiple phosphorylation sites in mammalian neurofilament polypeptides. , 1982, The Journal of biological chemistry.

[54]  R. Lasek,et al.  The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons , 1975, The Journal of cell biology.

[55]  S. Carpenter.  Proximal axonal enlargement in motor neuron disease , 1968, Neurology.

[56]  P M Steinert,et al.  Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.